In conclusion, the results presented in this study reveal the significant anti-inflammatory benefit of 25(OH)D3, a natural steroid hormone, against the development of DS and possibly ICH in patients with APL by reducing NF-κB nuclear translocation and the subsequent cytokine storm. Here, NFKB1 is linked to Dravet syndrome.